The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 07, 2017

Filed:

Oct. 31, 2012
Applicant:

Claus Selch Larsen, Lejre, DK;

Inventors:

Claus Selch Larsen, Lejre, DK;

Susan Weng Larsen, Rødvore, DK;

Mette Agergaard Thing, Copenhagen, DK;

Jesper Langgaard Kristensen, Copenhagen, DK;

Henrik Jensen, Roskilde, DK;

Jesper Østergaard, Farum, DK;

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); C07D 235/06 (2006.01); A61K 47/48 (2006.01); C07C 219/10 (2006.01); C07C 219/32 (2006.01); C07C 229/42 (2006.01); C07D 487/04 (2006.01); C07D 233/61 (2006.01); C07D 235/16 (2006.01); C07D 235/18 (2006.01); C07D 213/55 (2006.01);
U.S. Cl.
CPC ...
C07D 235/06 (2013.01); A61K 47/48023 (2013.01); A61K 47/48061 (2013.01); C07C 219/10 (2013.01); C07C 219/32 (2013.01); C07C 229/42 (2013.01); C07D 213/55 (2013.01); C07D 233/61 (2013.01); C07D 235/16 (2013.01); C07D 235/18 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention relates to novel depot formulations (prodrugs) comprising an immobility promoting unit linked via an ester to an active pharmaceutical ingredient, i.a. common NSAIDs. The novel depot formulations are suitable for intra-articular injections and are soluble at slightly acidic pH to facilitate ease of injection, and sparingly soluble at physiological pH thereby precipitating at the site of administration. The precipitate will slowly dissolve and the active drug is released from dissolved depot formulation following esterase mediated cleavage of the ester link between the immobility promoting unit and the active pharmaceutical agent.


Find Patent Forward Citations

Loading…